Report: Medicaid Overspends on Brand-Name Prescriptions
Medicaid overspent by at least $271 million in 2009 on brand-name drugs when generic alternatives existed, according to a new report by the American Enterprise Institute. AEI researchers examined two-thirds of the $21.8 billion Medicaid spent overall on pharmaceuticals last year and found 20 brand-name drugs that Medicaid commonly bought despite the presence of lower-cost generic alternatives.
- "Report: Medicaid Wasting Millions on Name-Brand Drugs" (Lillis, "Healthwatch," The Hill, 7/21).